Oriol Grau Rivera
Oriol Grau Rivera
Neurologist and investigator, BarcelonaBeta Brain Research Center
Verified email at barcelonabeta.org
Cited by
Cited by
A comprehensive study of the genetic impact of rare variants in SORL1 in European early-onset Alzheimer’s disease
J Verheijen, T Van den Bossche, J van der Zee, S Engelborghs, ...
Acta neuropathologica 132 (2), 213-224, 2016
Prevalence of amyloid‐β pathology in distinct variants of primary progressive aphasia
D Bergeron, ML Gorno‐Tempini, GD Rabinovici, MA Santos‐Santos, ...
Annals of neurology 84 (5), 729-740, 2018
Feasibility of lumbar puncture in the study of cerebrospinal fluid biomarkers for Alzheimer's disease: a multicenter study in Spain
D Alcolea, P Martínez-Lage, A Izagirre, M Clerigué, M Carmona-Iragui, ...
Journal of Alzheimer's Disease 39 (4), 719-726, 2014
Determination of neuronal antibodies in suspected and definite Creutzfeldt-Jakob disease
O Grau-Rivera, R Sánchez-Valle, A Saiz, JL Molinuevo, R Bernabé, ...
JAMA neurology 71 (1), 74-78, 2014
PrP mRNA and protein expression in brain and PrPc in CSF in Creutzfeldt-Jakob disease MM1 and VV2
F Llorens, B Ansoleaga, P Garcia-Esparcia, S Zafar, O Grau-Rivera, ...
Prion 7 (5), 383-393, 2013
Regional overlap of pathologies in Lewy body disorders
M Colom-Cadena, O Grau-Rivera, L Planellas, C Cerquera, E Morenas, ...
Journal of Neuropatholgy & Experimental Neurology 76 (3), 216-224, 2017
Centiloid cut-off values for optimal agreement between PET and CSF core AD biomarkers
G Salvadó, JL Molinuevo, A Brugulat-Serrat, C Falcon, O Grau-Rivera, ...
Alzheimer's research & therapy 11 (1), 1-12, 2019
Cerebrospinal fluid biomarkers predict clinical evolution in patients with subjective cognitive decline and mild cognitive impairment
A Sierra-Rio, M Balasa, J Olives, A Antonell, A Iranzo, M Castellví, ...
Neurodegenerative Diseases 16 (1-2), 69-76, 2016
Deleterious ABCA7 mutations and transcript rescue mechanisms in early onset Alzheimer’s disease
A De Roeck, T Van den Bossche, J van der Zee, J Verheijen, W De Coster, ...
Acta neuropathologica 134 (3), 475-487, 2017
Analysis of known amyotrophic lateral sclerosis and frontotemporal dementia genes reveals a substantial genetic burden in patients manifesting both diseases not carrying the …
O Dols-Icardo, A García-Redondo, R Rojas-García, D Borrego-Hernández, ...
Journal of Neurology, Neurosurgery & Psychiatry 89 (2), 162-168, 2018
Altered mechanisms of protein synthesis in frontal cortex in Alzheimer disease and a mouse model
P Garcia-Esparcia, G Sideris-Lampretsas, K Hernandez-Ortega, ...
American journal of neurodegenerative disease 6 (2), 15, 2017
Clinicopathological correlations and concomitant pathologies in rapidly progressive dementia: a brain bank series
O Grau-Rivera, E Gelpi, C Nos, C Gaig, I Ferrer, A Saiz, A Lladó, ...
Neurodegenerative Diseases 15 (6), 350-360, 2015
Frontotemporal dementia caused by the P301L mutation in the MAPT gene: clinicopathological features of 13 cases from the same geographical origin in Barcelona, Spain
S Borrego-Écija, J Morgado, L Palencia-Madrid, O Grau-Rivera, R Reñé, ...
Dementia and geriatric cognitive disorders 44 (3-4), 213-221, 2017
Neuronal intranuclear (hyaline) inclusion disease and fragile X-associated tremor/ataxia syndrome: a morphological and molecular dilemma
E Gelpi, T Botta-Orfila, L Bodi, S Marti, G Kovacs, O Grau-Rivera, ...
Brain 140 (8), e51-e51, 2017
Diagnostic accuracy of behavioral variant frontotemporal dementia consortium criteria (FTDC) in a clinicopathological cohort
M Balasa, E Gelpi, I Martín, A Antonell, MJ Rey, O Grau‐Rivera, ...
Neuropathology and applied neurobiology 41 (7), 882-892, 2015
Subtype and regional regulation of prion biomarkers in sporadic C reutzfeldt–J akob disease
F Llorens, S Zafar, B Ansoleaga, M Shafiq, R Blanco, M Carmona, ...
Neuropathology and applied neurobiology 41 (5), 631-645, 2015
Dementia with Lewy bodies: molecular pathology in the frontal cortex in typical and rapidly progressive forms
P Garcia-Esparcia, I López-González, O Grau-Rivera, MF García-Garrido, ...
Frontiers in neurology 8, 89, 2017
Novel tau biomarkers phosphorylated at T181, T217 or T231 rise in the initial stages of the preclinical Alzheimer’s continuum when only subtle changes in Aβ …
M Suárez‐Calvet, TK Karikari, NJ Ashton, J Lantero Rodriguez, ...
EMBO molecular medicine 12 (12), e12921, 2020
Association between insomnia and cognitive performance, gray matter volume, and white matter microstructure in cognitively unimpaired adults
O Grau-Rivera, G Operto, C Falcón, G Sánchez-Benavides, R Cacciaglia, ...
Alzheimer's research & therapy 12 (1), 1-14, 2020
Brain and cognitive correlates of subjective cognitive decline-plus features in a population-based cohort
G Sánchez-Benavides, O Grau-Rivera, M Suárez-Calvet, C Minguillon, ...
Alzheimer's research & therapy 10 (1), 1-13, 2018
The system can't perform the operation now. Try again later.
Articles 1–20